Revenue
2024
2025
CARLSMED, INC. (CARL)
Price—Loading quote
Net income
2024
2025
Free cash flow
2024
2025
Total cash / debt
CashTotal debt
2023
2024
2025
Financial statements
| 2025 | 2024 | |
|---|---|---|
| Revenue | $50.5M | $27.2M |
| Gross profit | $38.0M | $20.0M |
| Research & development | $17.0M | $14.3M |
| Operating expenses | $68.6M | $44.2M |
| Operating income | −$30.6M | −$24.1M |
| EBITDAderived | −$30.3M | −$24.0M |
| Net income | −$29.6M | −$24.3M |
| Basic EPSper diluted share | -$2.12 | -$6.11 |
| Diluted EPSper diluted share | -$2.12 | -$6.11 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 2, 2026Form 4 | Cordonnier MichaelCEO, President | SellCommon Stock | 197.9K | $13.29 | $2.63M | 1.36M |
| Jul 24, 2025Form 4 | B Capital Healthcare I, L.P. +4TenPercentOwner | BuyCommon Stock · indirect | 1.33M | $15.00 | $20.00M | 5.01M |
| Jul 24, 2025Form 4 | Sidow KevinDirector | BuyCommon Stock | 13.3K | $15.00 | $200.0K | 59.6K |
| Jul 24, 2025Form 4 | Mittendorff Robert IIDirector | BuyCommon Stock · indirect | 1.33M | $15.00 | $20.00M | 5.01M |
| Jul 24, 2025Form 4 | ROOT JONATHAN DDirector | BuyCommon Stock | 466.7K | $15.00 | $7.00M | 484.0K |